A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1210
https://www.valueinhealthjournal.com/article/S1098-3015(15)03286-6/fulltext
Title :
A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03286-6&doi=10.1016/j.jval.2015.09.1210
First page :
A464
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
711